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Utility of Routine Culture for Tuberculosis from Endobronchial 
Ultrasound-Guided Transbronchial Needle Aspiration in a Tuber-
culosis Endemic Country
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Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a technique 
developed to allow mediastinal staging of lung cancer and also to evaluate intrathoracic lymphadenopathy. In 
a tuberculosis-endemic area, tuberculosis should be considered as an etiology of mediastinal lymphadenopathy. 
The aim of this study was to investigate the utility of the routine culture for tuberculosis from specimens of 
EBUS-TBNA.
Methods: We prospectively performed routine culture for tuberculosis from aspiration or core biopsy specimens 
got from 86 patients who had undergone EBUS-TBNA due to mediastinal lymphadenopathy between March 2010 
and March 2011.
Results: A total of 135 lymph node aspiration and 118 core biopsy specimens were included in this analysis. We 
confirmed the malignancy in 62 (72.9%), tuberculosis in 7 (8.1%), sarcoidosis in 7 (8.1%), asperogillosis in 2 (2.3%) 
and pneumoconiosis in 2 (2.3%) patients. One lung cancer patient had pulmonary tuberculosis coincidentally and 
5 patients had unknown lymphadenopathy. The number of positive culture for Mycobacterium tuberculsosis by 
EBUS-TBNA is 2 (1.5%) from 135 lymph node aspiration specimens and 2 (1.7%) from 118 core biopsy specimens. 
Out of eight patients confirmed with tuberculosis, only one patient had positive mycobacterial culture of aspiration 
specimen from EBUS-TBNA without histopathologic diagnosis. 
Conclusion: These results propose that routine culture for tuberculosis from EBUS-TBNA may not provide additional 
information for the diagnosis of coincident tuberculous lymphadenitis. However, if there is any possibility of 
tuberculous lymphadenopathy or pulmonary tuberculosis, it should be considered to perform EBUS-TBNA in 
patients who have negative sputum AFB smears or no sputum production.
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Introduction
  Blind transbronchial needle aspiration (Blind TBNA) 
and endoscopic ultrasound guided fine needle aspira-
tion (EUS-FNA) are used to diagnose mediastinal lymph 
nodes metastases because mediastonoscopy requires 
general anesthesia. However, the sensitivity and the 
negative predict value of blind TBNA are known to be 
76% and 71% which indicates the low accuracy. More-
over, the sensitivity and the negative predict value of 
EUS-FNA are known to be 88% and 77%. The accuracy 
of EUS-FNA seems to be higher but the accessible area 
for the procedure is limited to the left posterior lymph 
nodes due to the anatomical location of esophagus1,2. 
Endoscopic ultrasound-guided fine needle aspiration 
(EBUS-TBNA) was developed to overcome these limi-
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tations of blind TBNA and EUS-FNA in late 2000 and 
has been used widely since then. This is the real-time 
lymph node biopsy with 22 G needles through the line-
ar array probe installed in bronchoscopy. This proce-
dure has reduced the complications related to general 
anesthesia and surgical procedures, and increased ac-
cessibility to subcarinal and parahilar lymph nodes 
where it was difficult to approach with thoracoscopy.
  The value of EBUS-TBNA in establishing the stage of 
lung cancer was proved in previous studies and 
Nakajima et al. proved that EBUS-TBNA was better to 
diagnose sarcoidosis than transbronchial lung biopsy 
(TBLB) and bronchoalveolar lavage (BAL)3. The pre-
vious study in a country with low prevalence of tuber-
culosis reported 46∼63% of microbiologic diagnosis 
rate and greater than 80% of pathological diagnosis rate 
for intrathoracic tuberculous lymphadenitis when EBUS- 
TBNA was performed4. Cancer patients are known to 
possess a higher risk of tuberculosis5-7. Unexpected tu-
berculous lymphadenitis was found in about 5.1% of 
lung cancer patients after Solak et al.8 performed media-
stinal lymph node biopsy using mediastinoscopy in 
Turkey and none of the patients were presented with 
any findings indicating tuberculous lymphadenitis in 
sputum culture and bronchoscopy. It is necessary to do 
pathological diagnostic examinations such as media-
stinoscopic biopsy because it is 15∼25% more probable 
to misdiagnose the stage of non-small cell lung carcino-
ma higher than the actual stage, when predicted with 
positron emission tomography (PET) due to the high 
lymphatic uptake in a tuberculosis endemic country9,10. 
Therefore, the possibility of tuberculous lymphadenitis 
should be considered. Currently, there is not any re-
search conducted regarding the utility of EBUS-TBNA to 
diagnose tuberculous lymphadenitis in a tuberculosis 
endemic country, South Korea. Therefore, this study 
was aimed to examine the value of routine culture for 
tuberculosis from EBUS-TBNA performed to distinguish 
tuberculous lymphadenitis from lung cancer or sarcoi-
dosis in the same way of the routine culture for tuber-




  This prospective observation study was conducted 
with outpatients and inpatients attended (total 86 pa-
tients) in Severance Hospital between March 2010 and 
March 2011 by performing routine culture for tuber-
culosis from EBUS-TBNA. EBUS-TBNA was performed 
to differentiate between malignancy and the other be-
nign disease when the causes of the enlarged lymph 
nodes larger than 1 cm of its axis identified in media-
stinum and pulmonary hilum on chest computed to-
mography (CT) scan were not obvious .The patients 
who were at high risk for fiberoptic bronchoscopy and 
those suffered from severe pulmonary disease, cardiac 
condition, liver disease, neurological defect or bleeding 
disorder were excluded.
2. Methods
  EBUS-TBNA was performed with an endobronchial 
ultrasound (model BF-UC260F; Olympus, Tokyo, Japan) 
and a 22-gauge needle (NA-201SX; Olympus) after fiber-
optic bronchoscopy (model BF-1T260, BF-260, or 
FB-6C260, Olympus, Japan). Specimen of all subject col-
lected by bronchial washing were tested for micro-
biology and cytology examination. The core tissues 
were obtained from lymph nodes by EBUS-TBNA, were 
fixed with 10% formalin, were made in slide and were 
reviewed by pathologists. The rest of the aspirated ma-
terials were smeared on the glass slides and fixed with 
95% alcohol for cytology examinations. In addition, the 
aspirated specimens were tested for acid-fast bacillus 
(AFB) stain and mycobacterium tuberculosis culture us-
ing MGIT-BACTEC 960 and ogawa. At the same time, 
the core tissues were tested for mycobacterium culture 
if they were aspirated.
  Tuberculous lymphadenitis was diagnosed either 
when granulomatous inflammation accompanying case-
ous necrosis was confirmed by core tissue examinations 
and histopathologic examinations or when there were 
positive results of AFB stain and mycobacterium tuber-
culosis culture as well as tuberculosis was identified in 
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Table 1. Results for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA)
Lymph node station* No. of nodes sampled at EBUS-TBNA (n=135)
No. of nodes from which have 
pathologic diagnosis for tuberculosis 
were obtained (n=3)
No. of nodes from which 
positive culture for tuberculosis 
were obtained (n=2)
 1 2 0 0
 2 6 1 0
 4R 47 1 1
 4L 7 0 0
 7 40 1 1
10R 14 0 0
10L 3 0 0
11R 10 0 0
11L 5 0 0
12 1 0 0
*According to Mountain-Dresler lymph node map.
1: low cervical, supraclavicular and sternal notch node; 2: upper paratracheal node; 4R: right lower paratracheal node; 4L: left lower
paratracheal node; 7: subcarinal node; 10R: right hilar node; 10L: left hilar node; 11R: right lobar node; 11L: left lobar node; 12R:
right segmental node.
other areas and the enlarged lymph nodes were im-
proved by tuberculosis treatment. Sarcoidosis was diag-
nosed when there were correspondent clinical symp-
toms, the specimen culture for mycobacterium tuber-
culosis and other bacteria was negative, the causes of 
allergy, occupational disease and malignancy were ex-
cluded and non-caseating epithelioid cell granulomata 
was pathologically confirmed3. This study was ap-
proved by Severance Hospital Institutional Review 
Board (4-2010-0050).
Results
  EBUS-TBNA was performed on 86 patients with sus-
pected perihilar and mediastinal lymphadenopathy 
(total 135 lymph nodes). The mean age of the subjects 
were 62.4 years old and 63 (73.3%) of them were male 
and 23 (26.7%) of them were female. Average 1.6 
lymph nodes per person were underwent EBUS-TBNA 
and the locations of lymph nodes were right para-
tracheal nodes (47, 34.8%), subcarinal lymph nodes (40, 
29.6%) and right hilar lymph nodes (14, 10.4%) in the 
order of frequency (Table 1).
  The final diagnoses of the subjects were cancer in 62 
patients (44 non-small cell carcinomas, 12 small cell car-
cinomas, 6 other types of tumors), 1 lung cancer accom-
panying tuberculosis, 7 cases of tuberculosis, 7 cases of 
sarcoidosis, 2 cases of aspergillosis and 2 cases of 
pneumoconiosis. Among total 63 cancer patients, the 
sensitivity of EBUS-TBNA aspirated specimen cytology 
test was 80.9% and the sensitivity of core tissue pathol-
ogy test was 76.2% (Tables 2, 3). Two of 7 sarcoidosis 
patients were at the stage I without any lung paren-
chymal lesions and the rest of 5 patients were accom-
panied with lung parenchymal lesions. One of them 
was diagnosed by TBLB and EBUS-TBNA, another pa-
tient was diagnosed by mediastinoscopy and the rest of 
5 patients were diagnosed by EBUS-TBNA. The patho-
logical findings corresponded to sarcoidosis were found 
in 8 aspirated specimens (57%) and 7 core tissues 
(70%).
  There were 8 confirmed tuberculosis patients and one 
of them was accompanied with lung cancer. One of 
them (12.5%) was diagnosed by EBUS-TBNA aspirated 
specimen cytology test and 3 of them were diagnosed 
after the observation of caseous necrosis on pathologic 
examinations of core tissues (37.5%). Among the pa-
tients with the positive mycobacterial culture result, 2 
of them were confirmed in aspirated specimens (25%) 
and 2 of them were confirmed in core tissues (25%) 
Tuberculosis and Respiratory Diseases Vol. 71. No. 6, Dec. 2011
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Table 2. Results of aspiration specimen from EBUS-TBNA
Final diagnosis No. of patients (n=86)
No. of patients diagnosed
by aspiration (n=57)
No. of aspiration 
(n=135)
No. of positive for 
M.TB culture (n=2)
Cancer 63 (73.3) 51 (80.9) 97
  Non small cell lung cancer 44 (51.1) 35 (79.5) 60
    Adenocarcinoma 26 (30.2) 21 (80.7) 37
    Squamous cell carcinoma 15 (17.4) 12 (80.0) 19
    Large cell carcinoma  1 (1.1)  0 (0)  1 0 (0)
    Non specified carcinoma  2 (2.3)  2 (100)  3
  Small cell lung cancer 13 (15.1) 13 (100) 26
    Small cell lung cancer with tuberculosis*  1 (1.1)  1 (100)  2
  Other cancer  6 (6.9)†  3 (50)‡ 11§
Tuberculosis  8 (9.3)  1 (12.5)  9 2 (25)
  Mediastinal TB Lymphadenopathy  2 (2.3)  0 (0)  2 1 (50)
  TP pleurisy＋pulmonary TB  1 (1.1)  0 (0)  1 0 (0)
  Pulmonary TB＋Lymphadenopathy*  5 (5.8)  1 (20)  6 1 (20)
Sarcoidosis  7 (8.1)  4 (57.1) 14
  Parenchymal＋  5 (5.8)  2 (40) 11 0 (0)
  Parenchymal−  2 (2.3)  2 (100)  3
Asperogillosis  2 (2.3)  0 (0)  2 0 (0)
Pneumoconiosis  2 (2.3)  0 (0)  4 0 (0)
Unkonwn mediastinal lymphadenopathy  5 (5.8)  1 (20)  9 0 (0)
Values are presented as number (%).
*The group of pulmonary TB and lymphadenopathy included one patient with both small cell lung cancer and tuberculosis at the
same time. One patient is overlapped. †MALToma, 1; Advanced gastric cancer, 1; Breast cancer, 1; Cervix cancer, 1; Angiosarcoma,
1; Oropharyngeal cancer, 1. ‡Advanced gastric cancer, 1; Breast cancer, 1; Cervix cancer, 1. §MALToma, 2; Advanced gastric
cancer, 2; Breast cancer, 2; Cervix cancer, 1; Angiosarcoma, 2; Oropharyngeal cancer, 2. M.TB: Mycobacterium Tuberculosis.
(Tables 2, 3). Polymerase chain reaction test for M. tu-
berculosis (TB-PCR) was also performed to total 8 cases 
of confirmed enlarged lymph nodes secondary to tuber-
culosis and one of them presented with a positive result 
showing 12.5% of sensitivity. Performing TB-PCR to 75 
patients with the other diagnosis apart from tuber-
culosis, all the patients were presented with a negative 
result indicating 100% specificity. Among 4 patients pre-
sented with correspondent findings to tuberculosis on 
EBUS-TBNA, 2 of them were mediastinal lymphadenop-
athy without lung parenchymal lesions and the other 2 
patients accompanied with lung parenchymal lesions 
additionally had mediastinoscopy and TBLB to aid the 
diagnosis. In detail, a case of tuberculosis was con-
firmed by core tissue histopathology test but mycobacte-
rial culture was negative and another patient showed 
positive TB-PCR and presented with caseating gran-
uloma on histopathologic examinations of TBLB of core 
tissues and lung parenchyma. The diagnosis of another 
patient was confirmed by mycobacterial culture of 
lymph node tissue, aspirated specimen and core tissue. 
There was only one patient who was diagnosed with 
tuberculosis by only mycobacterial culture without the 
pathologic confirmation of EBUS-TBNA aspirated speci-
men examinations. The patient was already confirmed 
as tuberculosis by pathologic examination through me-
diastinoscopy before it was confirmed by the myco-
bacterial culture result. Among 4 patients who were di-
agnosed with tuberculosis despite of the negative 
EBUS-TBNA result, one of them was diagnosed by thor-
acentesis and pleural biopsy. The other 3 patients were 
clinically diagnosed with tuberculosis through imaging 
tests, clinical symptoms, and improvement after admin-
istrating anti-tuberculosis medications. The tuberculosis 
accompanied with lung cancer was confirmed by AFB 
smear and started tuberculosis therapy prior to the ad-
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Figure 1. Flowchart of pa-
tients with tuberculosis un-
dergoing endobronchial ul-
trasound guided by trans-
bronchial needle aspiration 
(EBUS-TBNA). aMycobac-
terial culture of pleural fluid
was positive. PCR: poly-
merase chain reaction; 
MTB: mycobacterium tu-
berculosis; VATS: video- 
assisted thoracoscopic sur-
gery.
Table 3. Results of core biopsy from EBUS-TBNA
Final diagnosis No. of patients (n=86)
No. of patients diagnosed 
by core biopsy (n=55)
No. of core 
biopsy (n=118)
No. of positive for 
M.TB culture (n=2)
Cancer 63 (73.3) 48 (76.2) 87
  Non small cell lung cancer 44 (51.1) 32 (72.7) 52
    Adeno carcinoma 26 (30.2) 20 (76.9) 34
    Squamous cell carcinoma 15 (17.4) 11 (73.3) 14
    Large cell carcinoma  1 (1.1)  0 (0)  1 0 (0)
    Non specified carcinoma  2 (2.3)  1 (50)  3
  Small cell lung cancer 13 (15.1) 13 (100) 23
    Small cell lung cancer with tuberculosis*  1 (1.1)  1 (100)  2
Other cancer  6 (6.9)†  3 (50)‡ 10§
Tuberculosis  8 (9.3)  3 (37.5)  9 2 (25)
  Mediastinal TB Lymphadenopathy  2 (2.3)  2 (100)  2 1 (50)
  TP pleurisy＋pulmonary TB  1 (1.1)  0 (0)  1 0 (0)
  Pulmonary TB＋Lymphadenopathy*  5 (5.8)  1 (50)  6 1 (20)
Sarcoidosis  7 (8.1)  3 (42.8) 10
  Parenchymal＋  5 (5.8)  3 (60)  7 0 (0)
  Parenchymal−  2 (2.3)  0 (0)  3
Asperogillosis  2 (2.3)  1 (50)  2 0 (0)
Pneumoconiosis  2 (2.3)  0 (0)  2 0 (0)
Unkonwn mediastinal lymphadenopathy  5 (5.8)  0 (0)  9 0 (0)
Values are presented as number (%).
*The group of pulmonary TB and lymphadenopathy included one patient with both small cell lung cancer and tuberculosis at the
same time. One patient is overlapped. †MALToma, 1; Advanced gastric cancer, 1; Breast cancer, 1; Cervix cancer, 1; Angiosarcoma,
1; Oropharyngeal cancer, 1. ‡Advanced gastric cancer, 1; Breast cancer, 1; Cervix cancer, 1. §MALToma, 2; Advanced gastric
cancer, 1; Breast cancer, 2; Cervix cancer, 1; Angiosarcoma, 2; Oropharyngeal cancer, 2. M.TB: Mycobacterium Tuberculosis.
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mission but there was no evidence of tuberculosis on 
EBUS-TBNA (Figure 1). There were not any complica-
tions related to EBUS-TBNA such as bleeding or 
pneumothorax.
Discussion
  About 50 % of extrapulmonary tuberculosis is tuber-
culous lymphadenitis and it is the most common in 
childhood tuberculosis, but it has been increasing 
among adults in recent years. Tuberculous lymphadeni-
tis is the most prevalent in tuberculosis endemic country 
and it has been reported that it is most commonly seen 
in female and in the third to fifth decade domestically11. 
Although fine needle aspiration is usually performed to 
confirm tuberculous lymphadenitis12, the results can be 
ambiguous in many cases and its sensitivity is usually 
low. Moreover, specific characteristics are not identified 
in immunosuppressed patients such as acquired im-
mune deficiency syndrome even if granuloma is ob-
served. Therefore, excisional biopsy is necessary in 
some cases.
  Intrathoracic tuberculous lymphadenitis is shown in 
5∼7% of adult pulmonary tuberculosis and 2% of them 
are diagnosed without lung parenchyma lesions result-
ing low diagnostic rate with bronchoscopy13. Chest CT 
finding of tuberculous lymphadenitis is radiolucency in 
the middle of lymph nodes created by necrosis and en-
hancement in surrounding area indicating histopatho-
logical caseous necrosis. However, these findings are 
observed in only in 33∼75% of patients, so chest CT 
cannot be used for a definite diagnostic method14.
  Malignancy is usually suspected when the maximum 
standard uptake value (SUV) on PET is greater than 2.5 
but the value increases to the maximum level when 
there is active tuberculosis. Therefore, active tuber-
culosis cannot be differentiated from malignancy only 
by SUV and its specificity is low despite its high sensi-
tivity15,16. For this reason, the pathological diagnosis was 
necessary to diagnose tuberculous lymphadenitis and 
the diagnostic value of fine needle aspiration was re-
ported in a number of researches. According to the 
study of Ellison et al.17 conducted in the United States 
with less prevalence of tuberculosis, there were 58 AFB 
smear positives (24.4%) and 82 mycobacterium culture 
positives (34.4%) performing needle aspiration from 238 
lymph nodes of 180 tuberculosis patients and the sensi-
tivity was increased to 53% when AFB smear, myco-
bacterium culture and pathologic findings of granuloma 
were combined. Nayak et al.18 conducted a research 
performing fine needle aspiration to 21 human im-
munodeficiency virus (HIV) positive patients and 21 
HIV negative patients accompanied with tuberculous 
lymphadenitis and reported that the positive AFB smear, 
the positive mycobacterium culture and the positive 
pathological findings correspondent to tuberculosis 
were 61.9%, 23.8% and 14.3%, respectively in HIV pos-
itive patients, and 9.5%, 38.1% and 52.4% in HIV neg-
ative patients. These results suggested that the need for 
additional histological tests was higher in HIV negative 
patients than HIV positive patients.
  Ayed and Behbehani13 performed bronchoscopy and 
mediastinoscopy to isolated thoracic tuberculous lym-
phadenitis patients without lung parenchymal lesions at 
the same time. They reported that all tuberculous lym-
phadenitis was identified by mediastinoscopy but none 
of the mycobacterium culture from sputum identified tu-
berculosis and only 9% of the mycobacterium culture 
from bronchial washing identified tuberculosis. Chang 
et al.19 reported that tuberculosis was diagnosed from 
36% of sputum culture, 90% of peripheral lymph node 
biopsy and 75% of bronchoscopy among the pulmonary 
tuberculosis patients accompanied with tuberculous 
lymphadenitis. Cetinkaya et al. diagnosed 8 tuberculosis 
patients among 10 tuberculosis patients (80%) with only 
fine needle aspiration without any other diagnostic in-
vestigations20.
  Cancer patients carry 9 times higher risk of tuber-
culosis than general population4 and the prevalence of 
tuberculosis among lung cancer patients is reported to 
be 916 per 100,000 people (MSK series)5 or 901 per 
100,000 people (Gopalakrishnan)6. About 5.1% of lung 
cancer patients accompany with tuberculous lymphade-
nitis7 and 82.4% of bronchogenic carcinoma patients ac-
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companied with tuberculosis also show mediastinal 
lymphadenopathy21. Impaired cell-mediated immunity 
due to the characteristics of tumors themselves or che-
motherapy reactivates pulmonary tuberculosis and the 
survival rate of lung cancer patients with active tuber-
culosis is lower than those without22. Simultaneous tu-
berculosis therapy with chemotherapy is important in 
lung cancer patients because it is known that tuber-
culosis does not affect the clinical progress of lung can-
cer when it is treated appropriately23.
  EBUS-TBNA has been developed to establish the me-
diastinal stage and carries less risk of neurovascular 
damage and infection than surgical methods under gen-
eral anesthesia24. Kuo et al. performed EBUS-TBANA on 
lung cancer patients accompanied with enlarged lymph 
nodes less than 1cm in the tuberculosis endemic area 
and reported 80.6% sensitivity of EBUS-TBNA, 100% 
specificity, 100% positive predictive value and 85.7% 
negative predictive value to diagnose the tumor lym-
phatic invasion. This results showed the more superior 
results of EBUS-TBNA than 18% specificity and 44% 
positive predictive value of PET-CT25. Marcus et al. per-
formed EBUS-TBNA to 153 patients suspected of media-
stinal malignancy and confirmed sarcoidosis in 5.2% 
(8/153) of them26 and Nakajima proved that the diag-
nostic accuracy of EBUS-TBNA was higher than that of 
BAL or transbronchial lung biopsy for the patients sus-
pected of sarcoidosis3. Therefore, EBUS-TBNA became 
a standard diagnostic method for malignancy and sar-
coidosis but the researches regarding its diagnostic val-
ue for tuberculous lymphadenitis only started to be con-
ducted in recent years4,27. EBUS-TBNA is a useful meth-
od for the patients suspected of tuberculous lymphade-
nitis located in inaccessible place for the biopsy because 
it facilitates the diagnosis and drug sensitivity of cul-
tured tuberculosis can be tested through aspirated speci-
men and pathologic specimen of core tissue.
  Among 8 patients with negative results of AFB smear 
and mycobacterium culture of sputum and bronchial 
washing, four patients were diagnosed either histologi-
cally or by mycobacterium culture from EBUS-TBNA 
This result was correspondent to the conclusions in pre-
vious studies stating that EBUS-TBNA was useful to di-
agnose tuberculous lymphadenitis although the sensi-
tivity of mycobacterium culture and pathology tests of 
EBUS-TBNA was low in this study. However, the addi-
tional mycobacterium culture of aspirated specimen was 
not beneficial because only one case (1.4%) was diag-
nosed by mycobacterium culture of aspirated specimen 
and core tissue from lymph node and tuberculous lym-
phadenitis was already diagnosed by mediastinoscopy 
before the culture result was available.
  Only 1.5% of cancer patients accompanied with tu-
berculosis in this study whereas 5.2% of cancer patients 
accompanied with tuberculosis in the study of Solak. 
The reasons for lower incidence are small sample size 
and that additional surgical mediastinal lymph node bi-
opsy was not performed. Moreover, the selection bias 
should have been occured during lymph nodes se-
lection for EBUS-TBNA. The utility of EBUS TBNA was 
underestimated as a diagnostic tool for tuberculous lym-
phadenitis because EBUS TBNA was usually used for 
lymph node biopsy in cancer patients such as lung can-
cer in tertiary hospital. The sensitivity and the specificity 
of mycobacterium culture and pathology tests from 
EBUS-TBNA were 50% and 100% respectively which 
were lower than 95% and 100% in the study of Hassan 
et al.27. The sensitivity seems to be low because this 
study was conducted with mediastinal lymphadenitis in-
cluding cancer patients and a number of inactive lymph 
node lesions whereas the previous studies included the 
patients who were strongly suspected of intrathoracic 
tuberculous lymphadenitis without lung parenchyma 
lesions. The higher mycobacterium culture was ex-
pected if the subjects were limited to the patients with 
enlarged mediastinal lymph nodes or to the patients sus-
pected of tuberculous lymphadenitis presented with ra-
diolucency in the middle of lymph nodes. The sensi-
tivity of EBUS-TBNA was 100% as the diagnosis of all 
4 isolated mediastinal lymphadenopathy in this study. 
This result is similar to bigger scale of study on intra-
thoracic tuberculous lymphadenitis patients without 
lung parenchyma lesions presented with negative AFB 
smear and mycobacterium culture reporting 94% of sen-
Tuberculosis and Respiratory Diseases Vol. 71. No. 6, Dec. 2011
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sitivity4. However, the results of the previous study is 
not feasible to apply in South Korea with high preva-
lence of tuberculosis and low prevalence of HIV be-
cause they were conducted in the countries where the 
prevalence of tuberculosis was low and HIV positive pa-
tients were included. It is thought to be beneficial to 
conduct large scale of researches in tuberculosis en-
demic countries in order to examine the clinical role of 
EBUS-TBNA for tuberculosis lymphadenopathy.
  In conclusion, EBUS-TBNA is beneficial for isolated 
mediastinal lymphadenopathy which needs to exclude 
tuberculous lymphadenopathy when sputum collection 
is difficult or AFB smear is negative, but the advantage 
of additional routine AFB smear and mycobacterium 
culture of fine needle aspiration specimen to diagnose 
tuberculous lymphadenitis accompanied with malig-
nancy is not justified.
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